TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12628946

Group type: COMPARATOR
Intervention: Angioplasty
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Bare Stenting
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Heparin-coated Stenting
Number of subjects: 588
Study: 10566714

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (200 mg i.v. before stenting, followed by 250 mg orally twice per day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Endoscopic stenting alone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 58
Study: 10172792

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 100 mg twice daily for 5 days
Number of subjects: 575

Group type: COMPARATOR
Intervention: Phenoxymethylpenicillin 1 MIU 3 times daily for 10 days
Number of subjects: 575

Group type: COMPARATOR
Intervention: Amoxicillin-clavulanic acid 500/125 mg 3 times daily for 10 days
Number of subjects: 575
Study: 2019131

Group type: EXPERIMENTAL
Intervention: Selective flora suppression (polymyxin E, tobramycin, and amphotericin B)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Selective flora suppression
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (paste and suspension without antimicrobial agents)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All patients received cefotaxime during the first 4 days
Number of subjects: 200
Study: 6778548

Group type: EXPERIMENTAL
Intervention: Mobilisation at home with a plaster-of-Paris cylinder
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bed rest for 48 hours in hospital
Number of subjects: 0
Study: 31008734

Group type: EXPERIMENTAL
Intervention: Fresh RBC units (short-term storage)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Old RBC units (long-term storage)
Number of subjects: 0
Study: 28459161

Group type: EXPERIMENTAL
Intervention: 4 sessions of acupuncture
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 7 sessions of acupuncture
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10 sessions of acupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 45
Study: 26387117

Group type: EXPERIMENTAL
Intervention: Contact force (CF)‐guided ablation with a target CF of 20 g
Number of subjects: 120

Group type: COMPARATOR
Intervention: Blind group (operators blinded to CF information)
Number of subjects: 120
Study: 23858722

Group type: EXPERIMENTAL
Intervention: NIP without dysplasia
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: NIP with dysplasia
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: NIP with malignant transformation to SCC
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (NM)
Number of subjects: 55
Study: 22307382

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression therapy (3 h daily for 3 months)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no IPC therapy)
Number of subjects: 31
Study: 18815815

Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 40
Study: 17531002

Group type: EXPERIMENTAL
Intervention: Bivalent gp120 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-risk individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-risk individuals
Number of subjects: 0
Study: 10811335

Group type: COMPARATOR
Intervention: Wheat bran 20 g/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Olestra 20 g/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Olestra 40 g/day
Number of subjects: 60
Study: 8650463

Group type: EXPERIMENTAL
Intervention: Missile warfare exposure during the Gulf War
Number of subjects: 1045

Group type: EXPERIMENTAL
Intervention: Post-war condition
Number of subjects: 1045
Study: 1610651

Group type: EXPERIMENTAL
Intervention: Direct revascularization
Number of subjects: 143

Group type: COMPARATOR
Intervention: Crossover bypass
Number of subjects: 143
Study: 6720548

Group type: EXPERIMENTAL
Intervention: diltiazem (360 mg/day)
Number of subjects: 15
Study: 30696554

Group type: EXPERIMENTAL
Intervention: Steareth 30 toothpaste
Number of subjects: 30

Group type: COMPARATOR
Intervention: SLS toothpaste
Number of subjects: 30
Study: 29749262

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg every night)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxazepam (10 mg every night)
Number of subjects: 40
Study: 26912554

Group type: EXPERIMENTAL
Intervention: AST-120 (6 g in three divided doses per day)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Control (standard conventional treatment)
Number of subjects: 579
Study: 23968597

Group type: EXPERIMENTAL
Intervention: RESMENA diet
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (AHA guidelines)
Number of subjects: 93
Study: 22995597

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nursing presence
Number of subjects: 38
Study: 20013165

Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate (LC)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: High-Fat Low-Carbohydrate (HFLC)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Unrestricted (UR)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Ratios of MyoSUV(max) to liver SUV(max)
Number of subjects: 63
Study: 17903230

Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 16143691

Group type: EXPERIMENTAL
Intervention: Nicotine enema
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Corticosteroid foam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5-ASA enema
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Corticosteroid liquid enema
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall retention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall preference
Number of subjects: 24
Study: 12081277

Group type: EXPERIMENTAL
Intervention: High contextual interference condition
Number of subjects: 38

Group type: COMPARATOR
Intervention: Low contextual interference condition
Number of subjects: 38
Study: 10051494

Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg orally once daily for 52 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo for 26 weeks
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Lamivudine treatment
Number of subjects: 125
Study: 8777591

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional angiography and venography
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional arteriography and venography
Number of subjects: 13
Study: 2147377

Group type: COMPARATOR
Intervention: Enalapril maleate 20 mg once daily, increased to 40 mg once daily in 14 patients, with 12.5 mg hydrochlorothiazide added in 5 patients.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (2 weeks) followed by enalapril maleate treatment.
Number of subjects: 18
Study: 31145227

Group type: COMPARATOR
Intervention: Pubococcygeal (PC) sling
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rectus fascia sling
Number of subjects: 21
Study: 31425504

Group type: EXPERIMENTAL
Intervention: L-5-methyltetrahydrofolate (10.4 μg/100 ml)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Folic acid (10.0 μg/100 ml)
Number of subjects: 120
Study: 28574779

Group type: EXPERIMENTAL
Intervention: Higher-dose trastuzumab (HD) 10 mg/kg every 3 weeks
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) trastuzumab 6 mg/kg every 3 weeks
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Higher-dose trastuzumab (HD)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Standard-of-care (SoC) trastuzumab
Number of subjects: 248
Study: 25651246

Group type: EXPERIMENTAL
Intervention: Coronary-sinus reducing device
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 104
Study: 24280470

Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo ultrasound
Number of subjects: 100

Group type: COMPARATOR
Intervention: Time control
Number of subjects: 100
Study: 21453540

Group type: EXPERIMENTAL
Intervention: 10,000 steps/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: 30 minutes of walking/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between 10,000 steps and 30 minutes groups
Number of subjects: 30
Study: 20171351

Group type: EXPERIMENTAL
Intervention: 800 mg ibuprofen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 18157892

Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Numbing symptoms
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Avoidance and hyperarousal
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Reexperiencing
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Numbing
Number of subjects: 319
Study: 15868627

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Flare status
Number of subjects: 137
Study: 12468609

Group type: EXPERIMENTAL
Intervention: 75 g of dried mango with 5 g of fat, 5 d/wk for 4 mo
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 75 g of dried mango without fat, 5 d/wk for 4 mo
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: 60,000 micro g of vitamin A capsule at baseline
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo capsule at baseline
Number of subjects: 176
Study: 9618753

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) treatment, cumulative 3.5 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison with healthy adults
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Baseline plasma cortisol concentrations
Number of subjects: 19
Study: 9098473

Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) treatment (50% diluted)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semen untreated (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pellet-Swim-up (SU) treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Centrifugation on Discontinuous Percoll Gradient (MP) treatment
Number of subjects: 0
Study: 2694341

Group type: EXPERIMENTAL
Intervention: Furazolidone plus ORT
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo plus ORT
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Furazolidone plus ORT (in patients with fecal leukocytes)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo plus ORT (in patients with fecal leukocytes)
Number of subjects: 191
Study: 506799

Group type: EXPERIMENTAL
Intervention: Glucocorticoid administration for 24 hours during phenformin treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethanol administration to biguanide-treated diabetics
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenformin treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 10
Study: 31752000

Group type: EXPERIMENTAL
Intervention: Oral sodium bicarbonate with high target bicarbonate level of 25 ± 1 mEq/L
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard level of 22 ± 1 mEq/L (Control)
Number of subjects: 42
Study: 31537089

Group type: EXPERIMENTAL
Intervention: Zolpidem-CR
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 27615436

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg per day
Number of subjects: 350

Group type: COMPARATOR
Intervention: Naftopidil 75 mg per day
Number of subjects: 350
Study: 25345731

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion relieving pain
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pain (mild and moderate intensities)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 22
Study: 24085227

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 5963

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5963
Study: 21895745

Group type: EXPERIMENTAL
Intervention: Seasonal trivalent influenza vaccine followed by two doses of pandemic H1N1 2009 vaccine (Group 1)
Number of subjects: 117

Group type: COMPARATOR
Intervention: One dose of pandemic H1N1 2009 vaccine followed by simultaneous vaccination of seasonal trivalent vaccine and second dose of pandemic H1N1 2009 vaccine (Group 2)
Number of subjects: 117
Study: 20050436

Group type: EXPERIMENTAL
Intervention: Facility-based, multidisciplinary team-based education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured education programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education through dialysis centers
Number of subjects: 0
Study: 16790484

Group type: EXPERIMENTAL
Intervention: Tart cherry juice blend
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 14745745

Group type: EXPERIMENTAL
Intervention: Dyadic intervention (one‐to‐one support) with long‐term survivors (LTS) meeting 8 times in 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 30
Study: 11030199

Group type: EXPERIMENTAL
Intervention: Fecal lactoferrin (Lf) test
Number of subjects: 351

Group type: COMPARATOR
Intervention: Fecal occult blood (FOB) test
Number of subjects: 351
Study: 9315575

Group type: EXPERIMENTAL
Intervention: Arbutamine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 26
Study: 8397213

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coating
Number of subjects: 27

Group type: COMPARATOR
Intervention: Plasma-sprayed titanium alloy (Ti) coating
Number of subjects: 27
Study: 3741249

Group type: EXPERIMENTAL
Intervention: 2.5% aqueous phenylephrine hydrochloride
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2.5% viscous phenylephrine hydrochloride
Number of subjects: 30
Study: 28956169

Group type: EXPERIMENTAL
Intervention: Thermal mineral water treatment (n=26)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Tap water treatment (n=24)
Number of subjects: 50
Study: 27636759

Group type: EXPERIMENTAL
Intervention: Apadent Total Care toothpaste with nanocalciumhydroxyapatite
Number of subjects: 30
Study: 24793941

Group type: EXPERIMENTAL
Intervention: 4 Pillars Toolkit and early vaccine supplies
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 20
Study: 23106928

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 39
Study: 20618338

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 + Tanespimycin 50 mg/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 + Tanespimycin 175 mg/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m2 + Tanespimycin 340 mg/m2
Number of subjects: 0
Study: 18312589

Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg levodopa plus 25 mg carbidopa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16629292

Group type: EXPERIMENTAL
Intervention: Video glasses
Number of subjects: 24

Group type: COMPARATOR
Intervention: Video projector
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Video glasses and video projector
Number of subjects: 24
Study: 11916789

Group type: EXPERIMENTAL
Intervention: Rapacuronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mivacurium
Number of subjects: 0
Study: 9459643

Group type: EXPERIMENTAL
Intervention: Vena caval filter
Number of subjects: 400

Group type: COMPARATOR
Intervention: No filter
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 400
Study: 7624600

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 127

Group type: COMPARATOR
Intervention: 10% phenylephrine
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine in both eyes
Number of subjects: 127

Group type: COMPARATOR
Intervention: 10% phenylephrine in both eyes
Number of subjects: 127
Study: 2096482

Group type: EXPERIMENTAL
Intervention: Thymus gland preparations (Thymu‐Skin)
Number of subjects: 0
Study: 843177

Group type: EXPERIMENTAL
Intervention: Drug treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major role therapy (MRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regular medication adherence support (e.g., visiting nurse, long-acting medication)
Number of subjects: 0
Study: 30409278

Group type: EXPERIMENTAL
Intervention: TAVR with the SAPIEN XT valve
Number of subjects: 2032

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 2032

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 2032
Study: 27392024

Group type: EXPERIMENTAL
Intervention: Single-piece IOL
Number of subjects: 65

Group type: COMPARATOR
Intervention: Three-piece IOL
Number of subjects: 65
Study: 24597619

Group type: EXPERIMENTAL
Intervention: TMS paired with cyclic passive movement (400 pairs, 1 Hz)
Number of subjects: 7

Group type: COMPARATOR
Intervention: TMS (120% of the resting motor threshold-RMT) with muscle at rest
Number of subjects: 7
Study: 22696580

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs used in the MESS study
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: EEG abnormality
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: Treatment for partial seizures
Number of subjects: 1334
Study: 21029175

Group type: EXPERIMENTAL
Intervention: Voucher benefit (up to $250 per month with a 20% copayment)
Number of subjects: 1605
Study: 18842771

Group type: EXPERIMENTAL
Intervention: 800 mg dairy calcium supplementation per day for 5 weeks
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Slow-release caffeine (SRC; 300 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 10
Study: 16102616

Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Carotid Artery Stenting (CAS)
Number of subjects: 397
Study: 11847518

Group type: EXPERIMENTAL
Intervention: Microsatellite instability assessment in leukemic DNA from bone marrow
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cytogenetic analysis
Number of subjects: 43
Study: 10561643

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tulipan‐Bruner trocar
Number of subjects: 10
Study: 8908381

Group type: EXPERIMENTAL
Intervention: Fish oil (2.7 g/day eicosapentaenoic plus docosahexaenoic acid for 2 months, then 1.7 g/day for 4 more months)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 16
Study: 1985383

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 77
Study: 6613136

Group type: EXPERIMENTAL
Intervention: Fibrinogen cryoprecipitate, thrombin solution, and factor XIII concentrate used for gluing in suprapubic transvesical prostatectomy
Number of subjects: 0
Study: 31969184

Group type: EXPERIMENTAL
Intervention: paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab
Number of subjects: 0
Study: 31277659

Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy
Number of subjects: 359

Group type: COMPARATOR
Intervention: Transbronchial forceps biopsy
Number of subjects: 359
Study: 27091470

Group type: EXPERIMENTAL
Intervention: Vocal fry in unstressed syllables
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vocal fry occurrence
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Distance from stressed syllable
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vocal fry use variability
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Single-syllable nonwords
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Lexical stress impact
Number of subjects: 50
Study: 25958945

Group type: EXPERIMENTAL
Intervention: Overreaching-detraining (OR-DT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 24
Study: 24968985

Group type: EXPERIMENTAL
Intervention: 150 mg/day of quetiapine
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 300 mg/day of quetiapine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 22577652

Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BBM) without collagen membrane
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BBM) with collagen membrane
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison between BBM and BBM with collagen membrane
Number of subjects: 23
Study: 19064263

Group type: EXPERIMENTAL
Intervention: Reacted spermatozoa
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nonreacted spermatozoa
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Both reacted and nonreacted spermatozoa
Number of subjects: 71
Study: 17569063

Group type: EXPERIMENTAL
Intervention: 30% phenylephrine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 16236038

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (four doses of 100 mg over 2 days)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Caffeine (single 250 mg dose)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (four doses of 100 mg over 2 days) + Caffeine (single 250 mg dose)
Number of subjects: 7
Study: 11832877

Group type: EXPERIMENTAL
Intervention: Bench/step exercise with extremity loading (WT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bench/step exercise without extremity loading (NWT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-training controls (NTC)
Number of subjects: 44
Study: 10431944

Group type: EXPERIMENTAL
Intervention: Hostility-reduction intervention (N = 10)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Information-control group (N = 12)
Number of subjects: 22
Study: 7668949

Group type: EXPERIMENTAL
Intervention: Blank card, colorful photograph, no stimulus
Number of subjects: 6
Study: 2152233

Group type: EXPERIMENTAL
Intervention: Diltiazem, 240 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol (60 to 240 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 12